Devsmita Das, MD, MPH

Affiliations: 
Psychiatry VA Palo Alto Health Care System 
Area:
Down Syndrome, Alzheimer's disease
Google:
"Devsmita Das"
Mean distance: 17.43 (cluster 48)
 
SNBCP
Cross-listing: Alzheimer's Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Phillips C, Fahimi A, Das D, et al. (2016) Noradrenergic system in down syndrome and Alzheimer’s disease a target for therapy Current Alzheimer Research. 13: 68-83
Phillips C, Fahimi A, Das D, et al. (2015) Noradrenergic System in Down Syndrome and Alzheimer's Disease A Target for Therapy. Current Alzheimer Research
Das D, Medina B, Baktir MA, et al. (2015) Increased incidence of intermittent hypoxemia in the Ts65Dn mouse model of Down syndrome. Neuroscience Letters. 604: 91-6
Das D, Phillips C, Lin B, et al. (2015) Assessment of dendritic arborization in the dentate gyrus of the hippocampal region in mice. Journal of Visualized Experiments : Jove
Nosheny RL, Belichenko PV, Busse BL, et al. (2015) Increased cortical synaptic activation of TrkB and downstream signaling markers in a mouse model of Down Syndrome. Neurobiology of Disease. 77: 173-90
Phillips C, Akif Baktir M, Das D, et al. (2015) The Link Between Physical Activity and Cognitive Dysfunction in Alzheimer Disease. Physical Therapy. 95: 1046-60
Das D, Medina B, Baktir MA, et al. (2015) Increased incidence of intermittent hypoxemia in the Ts65Dn mouse model of Down syndrome Neuroscience Letters. 604: 91-96
Heller HC, Salehi A, Chuluun B, et al. (2014) Nest building is impaired in the Ts65Dn mouse model of Down syndrome and rescued by blocking 5HT2a receptors. Neurobiology of Learning and Memory. 116: 162-71
Ghasemi M, Phillips C, Trillo L, et al. (2014) The role of NMDA receptors in the pathophysiology and treatment of mood disorders. Neuroscience and Biobehavioral Reviews. 47: 336-58
Das D, Phillips C, Hsieh W, et al. (2014) Neurotransmitter-based strategies for the treatment of cognitive dysfunction in Down syndrome. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 54: 140-8
See more...